Conmed Corporation (CNMD) Upgraded by Zacks to NEUTRAL

Zacks Zacks Investment Research upgraded shares of Conmed Corporation (CNMD) from UNDERPERFORM to NEUTRAL on November 22, 2012, with a target price of $28.00.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

To get a free copy of the research report on Conmed Corporation (CNMD),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .

Be the first to comment

Leave a Reply